Company intelligence / Profile preview

Zillion Fine Chemicals

Wugu District, New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Zillion Fine Chemicals acts as a CDMO, supporting the development and GMP manufacturing of liposomes/LNPs for advanced and high-value pharmaceuticals. Clinical results are tied to client programs, but the company itself offers robust capabilities for scalable and compliant production

Therapeutic areas: NephrologyOncologyNeurologyImmunology
Modalities: LiposomeLipid nanoparticleSmall moleculePhospholipid
Industry: Contract Manufacturing Organization

Partnerships

Nippon Fine ChemicalAmaran Biotechbiotech/pharma firms in Taiwan and Japan

Beyond the preview

Go deeper on Zillion Fine Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zillion Fine Chemicals.

Explore the full profile